Analyst Price Target is $22.75
▲ +32.89% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for NextGen Healthcare in the last 3 months. The average price target is $22.75, with a high forecast of $26.00 and a low forecast of $20.00. The average price target represents a 32.89% upside from the last price of $17.12.
Current Consensus is
The current consensus among 4 polled investment analysts is to buy stock in NextGen Healthcare. This rating has held steady since April 2022, when it changed from a Hold consensus rating.
NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange. The company was founded by Sheldon Razin in 1974 and is headquartered in Irvine, CA.